TCERG1L抗体

+ +

•  

   

     The image is immunohistochemistry of paraffin-embedded Human liver cancer tissue using P12277(TCERG1L Antibody) at dilution 1/30. (Original magnification: ×200)    

  
  

The TCERG1L (Transcription Elongation Regulator 1-Like) antibody is a tool used to study the TCERG1L protein, a less characterized homolog of TCERG1. which is involved in transcriptional elongation and RNA splicing. TCERG1L shares structural similarities with TCERG1. including multiple FF-domains and a WW domain, suggesting roles in protein-protein interactions and modulation of RNA polymerase II activity. While TCERG1 is well-studied in transcriptional regulation and linked to neurological disorders, TCERG1L's precise functions remain under investigation. It is hypothesized to influence mRNA processing, chromatin remodeling, or cell cycle regulation, potentially impacting cancer or developmental pathways.

The antibody enables detection and localization of TCERG1L in cellular models, aiding research into its expression patterns and interactions. Studies using TCERG1L antibodies have explored its nuclear localization, co-localization with splicing factors, and differential expression in tissues. Emerging evidence links TCERG1L dysregulation to diseases like glioblastoma or ovarian cancer, though mechanistic insights are limited. Commercial TCERG1L antibodies are typically validated for applications like Western blotting, immunofluorescence, or immunohistochemistry, but specificity challenges may arise due to homology with TCERG1. Ongoing research aims to clarify its biological significance and therapeutic potential.